Why four-week intervals matter Four weeks is not arbitrary
60,61 These advancements aim to improve patient experience, compliance, and treatment outcomes
The glucagon receptor component is hypothesised to enhance energy expenditure and fat breakdown, which researchers believe may contribute to greater weight loss compared with dual or single agonists though this remains under investigation and has not been definitively established
If you are overweight or obese and have struggled to lose weight through diet and exercise alone, adding GLP-1 shots to your treatment plan may help you achieve your weight loss goals
What is retatrutide and how does it work
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, in some formulations, obesity